Guggenheim initiates Bicara Therapeutics stock with buy rating
ORIGINAL SOURCE →via Investing.com
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] Reliance reworks Jio IPO as fresh share sale
- [FINANCE] Australia stocks lower at close of trade; S&P/ASX 200 down 0.49%
- [FINANCE] Crypto Market News: AlphaPepe AI DEX Demo Hits 3k Users While Solana Price Prediction Eyes $500 - StreetInsider
- [FINANCE] Aramco CEO warns oil market disruption could last into 2027 as company profit sees 26% increase - Arabian Business
- [FINANCE] VLGC spot rates hit record highs
- [FINANCE] Bitcoin steadies near $81k with Iran tensions, US regulations in focus